Clinical Trial Update: Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GS-9674 (Cilofexor), and the Effect of Food on GS-9674 Pharmacokinetics and Pharmacodynamics [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, tolerability, PK/PD of GS-9674 (cilofexor) and effect of food on PK/PD in healthy volunteers; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• GS-9674 (cilofexor) (cilofexor)

Snippet

Sponsor: Gilead Sciences | Conditions: Nonalcoholic Steatohepatitis (NASH) | Phase 1 | Status: COMPLETED | Results posted: 2020-10-12